DUNAYEVICH; Eduardo

Patent Applications and Registrations

Patent applications and USPTO patent grants for DUNAYEVICH; Eduardo.The latest application filed is for "use of cannabidiol in the treatment of epileptic spasms".

Company Profile

5.7.18

DUNAYEVICH; Eduardo - Cambridge GB
Dunayevich; Eduardo - Westlake Village CA
Dunayevich; Eduardo - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Cannabidiol In The Treatment Of Epileptic Spasms App 20220257529 - GUY; Geoffrey ; et al.	2022-08-18
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus Grant 11,406,623 - Guy , et al. August 9, 2	2022-08-09
Increasing Drug Bioavailability In Naltrexone Therapy App 20220233520 - Flanagan; Shawn ; et al.	2022-07-28
Increasing Drug Bioavailability In Naltrexone Therapy App 20220105087 - Flanagan; Shawn ; et al.	2022-04-07
Increasing Drug Bioavailability In Naltrexone Therapy App 20220088007 - Flanagan; Shawn ; et al.	2022-03-24
Methods Of Treating Tuberous Sclerosis Complex With Cannabidiol And Everolimus App 20220040155 - GUY; Geoffrey ; et al.	2022-02-10
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus Grant 11,160,795 - Guy , et al. November 2, 2	2021-11-02
Methods Of Providing Weight Loss Therapy In Patients With Major Depression App 20210299119 - Dunayevich; Eduardo ; et al.	2021-09-30
Methods For Reducing Binge Or Compulsive Eating App 20210283126 - Dunayevich; Eduardo ; et al.	2021-09-16
Methods Of Treating Tuberous Sclerosis Complex With Cannabidiol And Everolimus App 20210267950 - GUY; Geoffrey ; et al.	2021-09-02
Methods of providing weight loss therapy in patients with major depression Grant 11,033,543 - Dunayevich , et al. June 15, 2	2021-06-15
Increasing Drug Bioavailability In Naltrexone Therapy App 20190358222 - Flanagan; Shawn ; et al.	2019-11-28
Methods Of Providing Weight Loss Therapy In Patients With Major Depression App 20190290640 - Dunayevich; Eduardo	2019-09-26
Methods For Treating Or Preventing Migraine Headache App 20190256607 - Sun; Hong ; et al.	2019-08-22
Methods of providing weight loss therapy in patients with major depression Grant 10,322,121 - Dunayevich , et al.	2019-06-18
Methods for treating or preventing migraine headache Grant 10,259,877 - Sun , et al.	2019-04-16
Methods For Treating Or Preventing Migraine Headache App 20160311913 - SUN; Hong ; et al.	2016-10-27
Methods Of Providing Weight Loss Therapy In Patients With Major Depression App 20160143903 - Dunayevich; Eduardo ; et al.	2016-05-26
Methods of providing weight loss therapy in patients with major depression Grant 9,248,123 - Dunayevich , et al. February 2, 2	2016-02-02
Methods For Reducing Binge Or Compulsive Eating App 20130252995 - Dunayevich; Eduardo ; et al.	2013-09-26
Increasing Drug Bioavailability In Naltrexone Therapy App 20130245056 - Flanagan; Shawn ; et al.	2013-09-19
Methods Of Providing Weight Loss Therapy In Patients With Major Depression App 20110172260 - Dunayevich; Eduardo ; et al.	2011-07-14

Company Registrations

SEC

0001396783

DUNAYEVICH EDUARDO

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.